Role of Tocilizumab in Severe CNS Inflammatory Presentations in Children
Neurology. 2026 Apr 28;106(8):e214926. doi: 10.1212/WNL.0000000000214926. Epub 2026 Apr 7. ABSTRACT OBJECTIVES: Anti-interleukin 6 receptor (anti-IL6R) therapies have been proven to reduce relapse rates in …